Cryogenic Stock Up by Over 3% Today
By Ankur Chandra | Published at: Jul 31, 2025 03:33 PM IST

Vadodara, July 31, 2025: Shares of Cryogenic OGS Ltd are up by 3.11% at Rs 136 at 3:10 p.m. today. The company has got a new order of Rs 34.26 lakhs.
Stock Snapshot (as of 2:20 PM IST)
| Metric | Value (₹) |
|---|---|
| Last Traded Price | 137.99 |
| Change (%) | +6.09 (+4.62%) |
| Previous Close | 131.90 |
| Day’s High | 138.50 |
| Day’s Low | 126.26 |
| VWAP | 132.58 |
| 52-Week High | 150.00 |
| 52-Week Low | 89.30 |
| Market Cap (Full) | ₹192.78 crore |
| Market Cap (Free Float) | ₹36.53 crore |
| Turnover | ₹1.86 crore |
New Order Highlights
Cryogenic OGS announced the receipt of a significant domestic purchase order worth ₹34.26 lakh (excluding taxes) from Endress and Hauser. This order covers a comprehensive range of terminal automation systems and their associated spares. The components included are Air Eliminators, Strainer cum Air Eliminators, Master Meter Skids, Additive Dosing Blocks, and Prover Tanks. The company is set to fulfil this order within 14 weeks under EXW–POR Incoterms, with freight charges to be billed separately at actual costs.
Deal Summary
| Parameter | Details |
|---|---|
| Buyer | Endress and Hauser |
| Order Value | ₹34,26,035 (Excl. Taxes) |
| Contract Type | Domestic Purchase Order |
| Delivery Timeline | 14 weeks |
| Related Party Involved | No |
| Promoter Group Interest | None |
What Does This Mean For The Investors?
- Positive Market Sentiment
The stock rose 4.62% intraday, signalling improved investor confidence after the new order announcement. Such reactions often reflect optimism about future revenue. - Revenue Visibility in the Near Term
The ₹34.26 lakh order adds short-term revenue visibility, helping investors gauge business momentum and project near-term cash flows. - Strengthening Industry Ties
Securing an order from Endress and Hauser, a reputed industrial player, shows growing trust in Cryogenic OGS’s products, which could lead to repeat or larger orders. - Specialised Product Demand
The order includes niche automation products like Prover Tanks and Additive Dosing Blocks, indicating Cryogenic OGS’s expertise in high-precision terminal solutions, an attractive segment for long-term growth. - Execution and Margin Outlook
With a fixed 14-week delivery schedule and no promoter conflict, efficient execution could support better margins, especially if freight recovery is managed well.
What’s Ahead For Cryogenic OGS Ltd
Cryogenic OGS is likely to benefit from increased visibility after securing a niche order from Endress and Hauser. This signals strong trust in its terminal automation capabilities and may attract similar high-value deals. Its focus on specialised equipment like Prover Tanks and Dosing Blocks positions it well in a precision-driven segment. Timely execution of the order can support margin expansion. If the company continues this order momentum, investor sentiment may strengthen further. However, sustaining growth beyond small orders remains key.
About the Company
Cryogenic OGS Ltd, formerly known as Cryogenic Liquide Pvt. Ltd., is a company listed on the BSE. Headquartered in Vadodara, the company specialises in the manufacturing of metering and filtering equipment primarily for the oil and gas sector. It serves the Indian market by supplying a diverse range of terminal automation solutions, which are extensively used across the country’s petroleum logistics infrastructure.
REF:https://www.bseindia.com/xml-data/corpfiling/AttachLive/beae904c-4dc6-4fb0-8315-ac3e63dbcbec.pdf
https://www.bseindia.com/xml-data/corpfiling/AttachLive/c221adc1-86fe-4583-b4b4-acd409747727.pdf
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations

